Free Trial

Ingevity (NGVT) Financials

Ingevity logo
$43.75 +2.86 (+7.00%)
Closing price 03:59 PM Eastern
Extended Trading
$43.75 0.00 (-0.01%)
As of 06:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Ingevity

Annual Income Statements for Ingevity

This table shows Ingevity's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Income / (Loss) Attributable to Common Shareholders
-430 -5.40 212 118 181 184 169 127 35 80 129
Consolidated Net Income / (Loss)
-430 -5.40 212 118 181 184 182 145 44 84 133
Net Income / (Loss) Continuing Operations
-430 -5.40 212 118 181 184 182 145 44 84 133
Total Pre-Tax Income
-536 -10 270 163 235 228 222 175 87 137 202
Total Operating Income
-276 83 324 290 273 271 253 191 102 156 216
Total Gross Profit
455 472 570 513 466 482 417 329 274 275 319
Total Revenue
1,406 1,692 1,668 1,392 1,216 1,293 1,134 972 908 958 1,036
Operating Revenue
1,406 1,692 1,668 1,392 1,216 1,293 1,134 972 908 958 1,036
Total Cost of Revenue
952 1,220 1,098 879 751 811 717 643 634 683 717
Operating Cost of Revenue
952 1,220 1,098 879 751 811 717 643 634 683 717
Total Operating Expenses
730 389 246 222 192 212 164 138 173 120 103
Selling, General & Admin Expense
167 184 199 179 149 163 132 106 114 110 108
Research & Development Expense
28 32 30 26 23 20 22 20 18 17 -
Impairment Charge
349 0.00 0.00 - - - - - - - -
Restructuring Charge
187 174 5.00 17 20 27 10 11 41 -7.50 -5.60
Total Other Income / (Expense), net
-260 -93 -54 -128 -38 -43 -31 -16 -15 -19 -14
Interest Expense
98 93 62 52 47 55 33 18 19 20 16
Interest & Investment Income
7.70 6.30 7.50 4.00 4.90 7.70 3.40 2.30 1.40 0.00 -
Other Income / (Expense), net
-170 -5.70 - -80 4.10 4.30 -1.00 -0.50 3.20 1.00 2.50
Income Tax Expense
-105 -4.70 58 45 54 44 40 30 43 52 70
Basic Earnings per Share
($11.85) ($0.15) $5.54 $2.97 $4.39 $4.39 $4.02 $3.00 $0.83 $1.89 $3.06
Weighted Average Basic Shares Outstanding
36.35M 36.24M 37.15M 39.00M 40.47M 41.83M 42.04M 42.13M 42.11M 42.10M -
Diluted Earnings per Share
($11.85) ($0.15) $5.50 $2.95 $4.37 $4.35 $3.97 $2.97 $0.83 $1.89 $3.06
Weighted Average Diluted Shares Outstanding
36.35M 36.24M 37.15M 39.00M 40.47M 41.83M 42.04M 42.13M 42.11M 42.10M -
Weighted Average Basic & Diluted Shares Outstanding
36.35M 36.24M 37.15M 39.00M 40.47M 41.83M 42.04M 42.13M 42.11M 42.10M -

Quarterly Income Statements for Ingevity

This table shows Ingevity's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
21 17 -107 -284 -56 -117 25 36 51 16 75
Consolidated Net Income / (Loss)
21 17 -107 -284 -56 -117 25 36 51 16 75
Net Income / (Loss) Continuing Operations
21 17 -107 -284 -56 -117 25 36 51 16 75
Total Pre-Tax Income
27 8.80 -138 -335 -72 -154 32 48 64 20 96
Total Operating Income
50 55 -2.30 -311 -17 -109 57 69 66 38 109
Total Gross Profit
113 102 130 123 100 60 129 153 130 105 176
Total Revenue
284 299 377 391 340 372 446 482 393 384 482
Operating Revenue
284 299 377 391 340 372 446 482 393 384 482
Total Cost of Revenue
171 197 247 267 240 312 317 329 262 278 306
Operating Cost of Revenue
171 197 247 267 240 312 317 329 262 278 306
Total Operating Expenses
63 47 132 435 117 168 73 84 65 68 67
Selling, General & Admin Expense
43 39 39 41 47 43 40 52 49 56 54
Research & Development Expense
7.70 7.30 6.70 7.30 6.80 7.20 7.80 8.00 8.80 7.20 7.60
Other Operating Expenses / (Income)
12 - - 24 63 - - 3.00 5.60 1.50 3.30
Restructuring Charge
0.00 87 87 13 0.30 126 25 21 1.90 3.10 1.90
Total Other Income / (Expense), net
-24 -47 -136 -23 -55 -45 -24 -22 -1.40 -18 -14
Interest & Investment Income
-19 77 -24 -23 -22 71 -23 -22 -20 45 -12
Other Income / (Expense), net
-4.10 - -112 - -32 - -1.30 - 18 - -2.00
Income Tax Expense
6.30 -7.80 -31 -51 -16 -37 6.90 12 13 4.10 20
Basic Earnings per Share
$0.56 $0.45 ($2.95) ($7.81) ($1.54) ($3.19) $0.70 $0.98 $1.36 $0.44 $1.99
Weighted Average Basic Shares Outstanding
36.46M 36.35M 36.35M 36.35M 36.33M 36.24M 36.23M 36.22M 36.33M 37.15M 37.37M
Diluted Earnings per Share
$0.56 $0.45 ($2.95) ($7.81) ($1.54) ($3.16) $0.69 $0.97 $1.35 $0.43 $1.98
Weighted Average Diluted Shares Outstanding
36.46M 36.35M 36.35M 36.35M 36.33M 36.24M 36.23M 36.22M 36.33M 37.15M 37.37M
Weighted Average Basic & Diluted Shares Outstanding
36.46M 36.35M 36.35M 36.35M 36.33M 36.24M 36.23M 36.22M 36.33M 37.15M 37.37M

Annual Cash Flow Statements for Ingevity

This table details how cash moves in and out of Ingevity's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Change in Cash & Equivalents
-25 28 -196 20 194 -13 -10 41 -1.90 9.90 8.40
Net Cash From Operating Activities
129 205 313 293 352 276 252 174 128 72 139
Net Cash From Continuing Operating Activities
129 205 313 293 352 276 252 157 128 72 139
Net Income / (Loss) Continuing Operations
-430 -5.40 212 118 181 184 182 145 44 84 133
Consolidated Net Income / (Loss)
-430 -5.40 212 118 181 184 182 145 44 84 133
Depreciation Expense
108 123 109 110 100 85 57 40 39 35 32
Non-Cash Adjustments To Reconcile Net Income
585 307 78 149 31 50 34 1.90 53 -2.80 -4.80
Changes in Operating Assets and Liabilities, net
-135 -219 -85 -84 47 -43 -14 -19 -2.30 -44 -22
Net Cash From Investing Activities
-80 -77 -552 -139 -111 -658 -414 -59 -126 -89 -97
Net Cash From Continuing Investing Activities
-80 -77 -552 -139 -111 -658 -414 -59 -126 -89 -97
Purchase of Property, Plant & Equipment
-78 -110 -143 -104 -82 -115 -94 -53 -57 -101 -102
Acquisitions
0.00 0.00 -345 -35 0.00 -538 -316 0.00 - - -
Purchase of Investments
-0.30 -2.40 -77 - - - -2.00 -4.00 -70 0.00 -
Sale and/or Maturity of Investments
0.00 32 15 0.00 0.00 - 1.10 1.00 0.00 0.00 0.00
Other Investing Activities, net
-1.60 3.40 -2.20 0.50 -29 -5.60 -4.10 -3.00 0.00 0.60 -1.00
Net Cash From Financing Activities
-70 -100 48 -133 -50 369 154 -58 -3.40 27 -32
Net Cash From Continuing Financing Activities
-70 -100 48 -133 -50 369 154 -58 -3.40 27 -32
Repayment of Debt
-471 -383 -972 -25 -882 -789 -7.10 -270 -13 -5.80 0.00
Repurchase of Common Equity
0.00 -92 -145 -109 -88 -6.40 -47 -6.60 0.00 0.00 -
Issuance of Debt
405 376 1,165 0.00 896 1,175 304 231 412 7.10 2.80
Other Financing Activities, net
-4.10 -0.80 1.00 1.60 24 -10 -0.40 -0.70 52 29 -31
Effect of Exchange Rate Changes
-4.20 -0.30 -6.00 -1.70 2.20 0.20 -1.40 - - - -1.60
Cash Interest Paid
85 83 55 48 40 48 26 16 15 6.50 6.50
Cash Income Taxes Paid
27 30 55 54 47 15 35 62 22 1.40 0.00

Quarterly Cash Flow Statements for Ingevity

This table details how cash moves in and out of Ingevity's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
4.30 -67 28 20 -6.80 18 17 -9.20 1.80 6.90 -59
Net Cash From Operating Activities
25 65 47 30 -12 46 105 48 5.30 99 100
Net Cash From Continuing Operating Activities
25 65 47 30 -12 46 105 48 5.30 99 100
Net Income / (Loss) Continuing Operations
21 17 -107 -284 -56 -117 25 36 51 16 75
Consolidated Net Income / (Loss)
21 17 -107 -284 -56 -117 25 36 51 16 75
Depreciation Expense
25 25 26 27 30 31 31 30 31 30 26
Non-Cash Adjustments To Reconcile Net Income
27 -16 152 367 83 158 76 51 22 28 14
Changes in Operating Assets and Liabilities, net
-47 39 -25 -81 -68 -26 -26 -68 -98 25 -15
Net Cash From Investing Activities
-12 -28 -17 -18 -16 -25 -32 -23 2.50 -407 -86
Net Cash From Continuing Investing Activities
-12 -28 -17 -18 -16 -25 -32 -23 2.50 -407 -86
Purchase of Property, Plant & Equipment
-10 -25 -18 -18 -17 -29 -34 -22 -25 -49 -36
Sale of Property, Plant & Equipment
3.60 - - - - - - - - - -
Other Investing Activities, net
-5.10 -2.80 0.60 0.30 0.30 4.50 3.50 -1.10 -3.50 1.10 -1.90
Net Cash From Financing Activities
-11 -98 -6.30 10 23 -6.50 -53 -35 -5.60 313 -72
Net Cash From Continuing Financing Activities
-11 -98 -6.30 10 23 -6.50 -53 -35 -5.60 313 -72
Repayment of Debt
-100 -351 -44 -20 -55 -143 -95 -85 -60 -59 -23
Issuance of Debt
92 254 38 31 81 137 42 108 90 377 -
Other Financing Activities, net
-3.00 -0.30 -0.40 -0.40 -3.00 -0.10 0.30 1.20 -2.20 0.80 0.70
Effect of Exchange Rate Changes
1.40 -5.80 5.40 -2.00 -1.80 2.70 -2.30 -0.30 -0.40 2.60 -1.40
Cash Interest Paid
15 24 19 25 17 25 18 25 15 19 7.20
Cash Income Taxes Paid
4.40 2.90 1.80 19 2.90 1.80 4.30 19 4.70 12 16

Annual Balance Sheets for Ingevity

This table presents Ingevity's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Assets
2,023 2,623 2,737 2,469 2,335 2,142 1,315 930 833 779
Total Current Assets
493 659 683 725 629 463 423 369 295 296
Cash & Equivalents
68 96 77 275 258 57 78 88 31 32
Accounts Receivable
141 - 225 - - 150 119 100 90 95
Inventories, net
227 309 335 241 189 213 191 160 151 149
Prepaid Expenses
57 72 47 47 34 44 35 21 24 20
Plant, Property, & Equipment, net
659 762 799 0.00 0.00 0.00 524 439 423 438
Total Noncurrent Assets
871 1,203 1,255 1,744 1,706 1,679 369 122 115 45
Goodwill
175 528 519 442 445 436 131 12 12 12
Intangible Assets
279 336 405 338 373 396 126 4.90 7.30 10
Noncurrent Deferred & Refundable Income Taxes
118 12 5.70 6.80 8.10 5.00 2.90 3.40 3.40 0.00
Other Noncurrent Operating Assets
299 327 326 958 879 841 110 102 92 23
Total Liabilities & Shareholders' Equity
2,023 2,623 2,737 2,469 2,335 2,142 1,315 930 833 779
Total Liabilities
1,827 1,992 2,038 1,795 1,692 1,611 977 652 698 261
Total Current Liabilities
264 363 304 269 223 216 183 153 137 100
Short-Term Debt
61 84 0.90 20 26 23 11 9.40 7.50 9.40
Accounts Payable
95 158 175 126 104 99 93 83 79 65
Accrued Expenses
58 72 54 52 47 33 37 20 19 15
Current Deferred & Payable Income Tax Liabilities
5.60 9.20 3.60 6.20 5.30 15 0.50 1.50 5.30 0.80
Current Employee Benefit Liabilities
28 20 53 48 25 28 42 39 26 10
Other Current Liabilities
17 19 17 17 16 17 0.00 - - -
Total Noncurrent Liabilities
1,563 1,629 1,735 1,526 1,469 1,395 793 499 561 162
Long-Term Debt
1,340 1,383 1,473 1,250 1,267 1,228 741 444 481 80
Noncurrent Deferred & Payable Income Tax Liabilities
56 71 107 115 117 100 37 41 70 74
Other Noncurrent Operating Liabilities
167 175 156 162 85 67 15 13 10 7.20
Commitments & Contingencies
0.00 0.00 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
195 631 698 674 642 531 339 278 135 517
Total Preferred & Common Equity
195 631 698 674 642 531 339 264 127 514
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
195 631 698 674 642 531 339 264 127 514
Common Stock
177 165 153 137 122 113 99 141 130 0.00
Retained Earnings
572 1,002 1,008 796 678 497 314 143 16 0.00
Treasury Stock
-513 -510 -416 -272 -162 -75 -56 -7.70 -0.30 0.00
Accumulated Other Comprehensive Income / (Loss)
-41 -27 -47 13 4.70 -5.00 -18 -12 -19 -17

Quarterly Balance Sheets for Ingevity

This table presents Ingevity's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 3/31/2025 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets
2,056 2,212 2,276 2,567 2,767 2,828 2,772 2,335
Total Current Assets
530 637 686 669 735 764 716 645
Cash & Equivalents
72 136 107 89 85 68 78 72
Accounts Receivable
164 190 213 191 217 260 240 -
Inventories, net
245 261 302 326 387 387 361 282
Prepaid Expenses
49 50 63 64 47 50 37 43
Plant, Property, & Equipment, net
656 671 722 727 800 801 805 721
Total Noncurrent Assets
870 904 868 1,171 1,232 1,263 1,251 970
Goodwill
181 187 177 526 520 527 522 388
Intangible Assets
277 299 296 303 376 394 399 272
Noncurrent Deferred & Refundable Income Taxes
120 114 81 24 6.10 7.00 7.40 6.90
Other Noncurrent Operating Assets
293 304 315 319 331 335 323 303
Total Liabilities & Shareholders' Equity
2,056 2,212 2,276 2,567 2,767 2,828 2,772 2,335
Total Liabilities
1,822 1,997 1,991 1,999 2,048 2,114 2,047 1,702
Total Current Liabilities
265 361 358 352 305 311 279 290
Short-Term Debt
60 101 103 85 3.00 0.90 0.90 0.90
Accounts Payable
108 97 142 153 197 204 174 165
Accrued Expenses
57 117 70 71 65 64 55 57
Current Deferred & Payable Income Tax Liabilities
4.20 4.70 2.70 8.00 5.40 5.10 11 6.80
Current Employee Benefit Liabilities
19 24 21 17 17 20 22 45
Other Current Liabilities
16 18 19 19 18 18 16 16
Total Noncurrent Liabilities
1,557 1,636 1,634 1,647 1,743 1,803 1,768 1,411
Long-Term Debt
1,333 1,398 1,401 1,409 1,470 1,526 1,503 1,153
Noncurrent Deferred & Payable Income Tax Liabilities
59 66 62 64 105 110 108 107
Other Noncurrent Operating Liabilities
165 173 171 174 168 168 158 151
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
235 215 285 568 719 714 726 634
Total Preferred & Common Equity
235 215 285 568 719 714 726 634
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
235 215 285 568 719 714 726 634
Common Stock
181 175 172 170 163 164 159 148
Retained Earnings
593 555 663 946 1,119 1,094 1,058 992
Treasury Stock
-515 -513 -512 -512 -510 -510 -453 -411
Accumulated Other Comprehensive Income / (Loss)
-24 -3.50 -38 -36 -54 -34 -39 -95

Annual Metrics And Ratios for Ingevity

This table displays calculated financial ratios and metrics derived from Ingevity's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-16.88% 1.43% 19.89% 14.42% -5.94% 14.05% 16.58% 7.06% -5.22% -7.46% 0.00%
EBITDA Growth
-268.85% -53.85% 35.05% -13.52% 2.97% 19.30% 27.20% 72.06% -27.93% -23.76% 0.00%
EBIT Growth
-679.32% -76.26% 53.87% -24.09% 0.91% 9.22% 32.00% 81.70% -33.01% -28.33% 0.00%
NOPAT Growth
-433.78% -77.26% 20.67% -0.06% -3.32% 5.31% 30.43% 205.84% -45.99% -32.19% 0.00%
Net Income Growth
-7,868.52% -102.55% 79.17% -34.90% -1.25% 1.05% 25.21% 227.03% -47.33% -36.43% 0.00%
EPS Growth
-7,800.00% -102.73% 86.44% -32.49% 0.46% 9.57% 33.67% 257.83% -56.08% -38.24% 0.00%
Operating Cash Flow Growth
-37.30% -34.56% 6.85% -16.77% 27.82% 9.40% 44.58% 36.28% 77.15% -47.87% 0.00%
Free Cash Flow Firm Growth
87.52% 186.88% -178.37% -14.61% 152.31% -202.51% -250.73% 220.22% 107.06% 0.00% 0.00%
Invested Capital Growth
-23.69% -4.41% 25.60% -0.58% -2.75% 70.21% 57.54% 8.52% 3.15% 0.00% 0.00%
Revenue Q/Q Growth
-4.93% -0.70% 2.94% 0.75% 1.86% 1.96% 4.53% 1.95% 1.17% 0.00% 0.00%
EBITDA Q/Q Growth
-3.44% -42.88% -2.06% -8.43% 2.55% 6.77% 1.62% 12.37% -5.62% 0.00% 0.00%
EBIT Q/Q Growth
-1.30% -66.17% -3.31% -12.84% 4.96% 5.41% 5.18% 11.99% -3.41% 0.00% 0.00%
NOPAT Q/Q Growth
37.31% -67.23% -2.82% -5.53% 0.16% 1.27% -3.67% 33.38% 10.28% 0.00% 0.00%
Net Income Q/Q Growth
23.67% -104.25% -6.08% -12.39% 0.95% 1.21% -3.14% 33.33% 8.29% 0.00% 0.00%
EPS Q/Q Growth
23.35% -104.36% -5.66% -10.61% 1.16% 1.64% 0.51% 6.83% 295.24% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
16.59% -20.32% 7.62% -20.79% 23.82% -0.04% 21.68% -6.99% 15.02% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
26.96% 169.90% -188.66% -24.55% 45.91% -8.40% 10.53% -14.11% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
-3.11% -4.95% 22.11% 1.15% -2.35% 2.40% -0.05% 4.31% -4.95% 0.00% 0.00%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
32.33% 27.89% 34.17% 36.85% 38.28% 37.28% 36.77% 33.83% 30.21% 28.74% 30.76%
EBITDA Margin
-23.98% 11.80% 25.94% 23.03% 30.47% 27.83% 26.61% 24.38% 15.17% 19.95% 24.22%
Operating Margin
-19.60% 4.88% 19.42% 20.87% 22.47% 20.92% 22.28% 19.65% 11.20% 16.24% 20.86%
EBIT Margin
-31.68% 4.54% 19.42% 15.13% 22.80% 21.25% 22.19% 19.60% 11.55% 16.34% 21.10%
Profit (Net Income) Margin
-30.60% -0.32% 12.68% 8.49% 14.92% 14.21% 16.04% 14.93% 4.89% 8.80% 12.81%
Tax Burden Percent
80.34% 53.47% 78.49% 72.54% 77.16% 80.61% 81.97% 83.07% 51.03% 61.76% 65.61%
Interest Burden Percent
120.22% -13.13% 83.24% 77.34% 84.78% 82.93% 88.16% 91.71% 82.94% 87.16% 92.49%
Effective Tax Rate
0.00% 0.00% 21.51% 27.46% 22.84% 19.39% 18.03% 16.93% 48.97% 38.24% 34.39%
Return on Invested Capital (ROIC)
-10.93% 2.82% 13.51% 12.59% 12.39% 15.92% 24.99% 25.68% 8.89% 33.44% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
-28.48% -1.75% 9.95% 3.47% 9.75% 12.25% 20.14% 22.39% 5.98% -7.66% 0.00%
Return on Net Nonoperating Assets (RNNOA)
-93.18% -3.63% 17.33% 5.36% 18.54% 26.33% 33.98% 44.72% 4.73% -0.85% 0.00%
Return on Equity (ROE)
-104.11% -0.81% 30.84% 17.95% 30.93% 42.25% 58.97% 70.40% 13.62% 32.59% 0.00%
Cash Return on Invested Capital (CROIC)
15.95% 7.33% -9.18% 13.18% 15.17% -36.04% -19.69% 17.51% 5.79% -166.56% 0.00%
Operating Return on Assets (OROA)
-19.18% 2.87% 12.44% 8.76% 12.39% 15.90% 22.42% 21.63% 13.02% 20.11% 0.00%
Return on Assets (ROA)
-18.52% -0.20% 8.13% 4.92% 8.11% 10.63% 16.20% 16.48% 5.51% 10.83% 0.00%
Return on Common Equity (ROCE)
-104.11% -0.81% 30.84% 17.95% 30.93% 42.25% 57.63% 66.71% 13.38% 32.35% 0.00%
Return on Equity Simple (ROE_SIMPLE)
-220.44% -0.86% 30.30% 17.53% 28.25% 34.61% 53.68% 55.02% 34.96% 16.41% 0.00%
Net Operating Profit after Tax (NOPAT)
-193 58 254 211 211 218 207 159 52 96 142
NOPAT Margin
-13.72% 3.42% 15.24% 15.14% 17.33% 16.86% 18.26% 16.32% 5.71% 10.03% 13.69%
Net Nonoperating Expense Percent (NNEP)
17.55% 4.57% 3.57% 9.12% 2.64% 3.67% 4.85% 3.29% 2.91% 41.10% 0.00%
Return On Investment Capital (ROIC_SIMPLE)
-12.09% 2.76% 11.71% - - - - - - - -
Cost of Revenue to Revenue
67.67% 72.11% 65.83% 63.15% 61.72% 62.72% 63.23% 66.17% 69.79% 71.26% 69.24%
SG&A Expenses to Revenue
11.85% 10.86% 11.92% 12.89% 12.29% 12.62% 11.68% 10.94% 12.54% 11.47% 10.44%
R&D to Revenue
2.00% 1.88% 1.82% 1.89% 1.86% 1.52% 1.90% 2.04% 1.94% 1.82% 0.00%
Operating Expenses to Revenue
51.93% 23.01% 14.76% 15.98% 15.81% 16.36% 14.48% 14.18% 19.01% 12.50% 9.90%
Earnings before Interest and Taxes (EBIT)
-446 77 324 211 277 275 252 191 105 157 219
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-337 200 433 320 371 360 302 237 138 191 251
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
7.59 2.71 3.77 4.18 4.87 6.89 10.37 11.25 18.19 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 42.63 12.04 21.53 0.00 0.00
Price to Revenue (P/Rev)
1.05 1.01 1.58 2.02 2.57 2.83 3.10 3.05 2.54 0.00 0.00
Price to Earnings (P/E)
0.00 0.00 12.44 23.85 17.23 19.89 20.77 23.46 65.64 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 8.04% 4.19% 5.80% 5.03% 4.81% 4.26% 1.52% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.84 1.54 1.92 2.28 2.48 2.81 4.13 5.20 4.68 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
2.00 1.82 2.42 2.74 3.42 3.75 3.69 3.44 3.06 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 15.43 9.31 11.89 11.23 13.48 13.88 14.12 20.15 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 40.08 12.44 18.10 15.01 17.65 16.64 17.56 26.47 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 53.31 15.85 18.09 19.74 22.24 20.22 21.09 53.49 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
21.88 15.03 12.86 12.99 11.81 17.59 16.62 19.20 21.71 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
10.00 20.53 0.00 17.29 16.12 0.00 0.00 30.93 82.14 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
7.18 2.32 2.11 1.88 2.01 2.36 2.22 1.63 3.63 0.17 0.00
Long-Term Debt to Equity
6.86 2.19 2.11 1.86 1.97 2.31 2.19 1.60 3.58 0.15 0.00
Financial Leverage
3.27 2.08 1.74 1.54 1.90 2.15 1.69 2.00 0.79 0.11 0.00
Leverage Ratio
5.62 4.03 3.79 3.65 3.82 3.98 3.64 4.27 2.47 1.51 0.00
Compound Leverage Factor
6.76 -0.53 3.16 2.82 3.24 3.30 3.21 3.92 2.05 1.31 0.00
Debt to Total Capital
87.77% 69.91% 67.85% 65.33% 66.83% 70.21% 68.96% 62.00% 78.41% 14.73% 0.00%
Short-Term Debt to Total Capital
3.84% 4.02% 0.04% 1.01% 1.34% 1.26% 1.03% 1.29% 1.20% 1.55% 0.00%
Long-Term Debt to Total Capital
83.93% 65.89% 67.80% 64.32% 65.48% 68.95% 67.93% 60.71% 77.21% 13.18% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.91% 1.22% 0.63% 0.00%
Common Equity to Total Capital
12.23% 30.09% 32.15% 34.67% 33.17% 29.79% 31.04% 36.09% 20.37% 84.64% 0.00%
Debt to EBITDA
-4.15 7.35 3.41 3.96 3.49 3.48 2.49 1.91 3.55 0.47 0.00
Net Debt to EBITDA
-3.95 6.87 3.23 3.10 2.80 3.32 2.24 1.54 3.33 0.30 0.00
Long-Term Debt to EBITDA
-3.97 6.92 3.40 3.90 3.42 3.41 2.46 1.87 3.49 0.42 0.00
Debt to NOPAT
-7.26 25.38 5.80 6.03 6.14 5.74 3.63 2.86 9.42 0.93 0.00
Net Debt to NOPAT
-6.91 23.72 5.49 4.72 4.91 5.48 3.26 2.30 8.83 0.60 0.00
Long-Term Debt to NOPAT
-6.94 23.92 5.79 5.93 6.01 5.63 3.58 2.80 9.27 0.83 0.00
Altman Z-Score
0.99 1.93 2.46 2.46 2.64 2.85 4.20 4.95 3.75 0.00 0.00
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.27% 5.24% 1.75% 0.73% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.87 1.81 2.25 2.70 2.81 2.15 2.31 2.41 2.16 2.97 0.00
Quick Ratio
0.79 0.77 0.99 1.63 1.82 0.96 1.07 1.23 0.88 1.27 0.00
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
282 150 -173 220 258 -494 -163 108 34 -479 0.00
Operating Cash Flow to CapEx
165.72% 186.79% 219.93% 282.56% 429.23% 240.16% 268.37% 331.37% 225.57% 71.56% 136.05%
Free Cash Flow to Firm to Interest Expense
2.88 1.61 -2.80 4.26 5.48 -9.04 -4.91 5.98 1.75 -23.82 0.00
Operating Cash Flow to Interest Expense
1.31 2.20 5.07 5.67 7.48 5.05 7.59 9.63 6.63 3.59 8.45
Operating Cash Flow Less CapEx to Interest Expense
0.52 1.02 2.77 3.67 5.74 2.95 4.76 6.72 3.69 -1.43 2.24
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.61 0.63 0.64 0.58 0.54 0.75 1.01 1.10 1.13 1.23 0.00
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 9.62 10.36 10.25 9.82 10.07 0.00
Inventory Turnover
3.55 3.79 3.81 4.09 3.74 4.02 4.08 4.14 4.22 4.59 0.00
Fixed Asset Turnover
1.98 2.17 0.00 0.00 0.00 0.00 2.36 2.26 2.11 2.19 0.00
Accounts Payable Turnover
7.53 7.32 7.31 7.64 7.38 8.45 8.15 7.93 8.80 10.54 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 37.96 35.24 35.62 37.17 36.26 0.00
Days Inventory Outstanding (DIO)
102.71 96.29 95.75 89.35 97.62 90.90 89.47 88.27 86.40 79.58 0.00
Days Payable Outstanding (DPO)
48.50 49.84 49.95 47.77 49.43 43.21 44.81 46.04 41.46 34.63 0.00
Cash Conversion Cycle (CCC)
54.21 46.46 45.80 41.58 48.19 85.65 79.90 77.86 82.11 81.21 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,528 2,003 2,095 1,668 1,678 1,725 1,014 643 593 575 0.00
Invested Capital Turnover
0.80 0.83 0.89 0.83 0.71 0.94 1.37 1.57 1.56 3.33 0.00
Increase / (Decrease) in Invested Capital
-475 -92 427 -9.80 -47 712 370 51 18 575 0.00
Enterprise Value (EV)
2,814 3,082 4,029 3,811 4,162 4,849 4,187 3,347 2,776 0.00 0.00
Market Capitalization
1,481 1,711 2,632 2,817 3,126 3,655 3,512 2,968 2,310 0.00 0.00
Book Value per Share
$5.37 $17.43 $18.69 $17.15 $15.55 $12.69 $8.07 $6.27 $3.02 $12.20 $0.00
Tangible Book Value per Share
($7.12) ($6.41) ($6.02) ($2.69) ($4.28) ($7.22) $1.96 $5.86 $2.55 $11.68 $0.00
Total Capital
1,596 2,099 2,172 1,943 1,936 1,782 1,091 731 623 607 0.00
Total Debt
1,401 1,467 1,473 1,270 1,293 1,251 752 453 489 89 0.00
Total Long-Term Debt
1,340 1,383 1,473 1,250 1,267 1,228 741 444 481 80 0.00
Net Debt
1,333 1,371 1,397 994 1,036 1,194 675 366 458 57 0.00
Capital Expenditures (CapEx)
78 110 143 104 82 115 94 53 57 101 102
Debt-free, Cash-free Net Working Capital (DFCFNWC)
222 284 304 200 174 214 173 137 135 174 0.00
Debt-free Net Working Capital (DFNWC)
290 380 381 476 431 270 251 225 166 206 0.00
Net Working Capital (NWC)
229 296 380 456 405 248 239 216 158 197 0.00
Net Nonoperating Expense (NNE)
237 63 43 93 29 34 25 14 7.50 12 9.12
Net Nonoperating Obligations (NNO)
1,333 1,371 1,397 994 1,036 1,194 675 366 458 57 0.00
Total Depreciation and Amortization (D&A)
108 123 109 110 93 85 50 47 33 35 32
Debt-free, Cash-free Net Working Capital to Revenue
15.81% 16.80% 18.22% 14.39% 14.28% 16.53% 15.27% 14.09% 14.90% 18.15% 0.00%
Debt-free Net Working Capital to Revenue
20.65% 22.46% 22.82% 34.18% 35.47% 20.90% 22.11% 23.13% 18.25% 21.49% 0.00%
Net Working Capital to Revenue
16.29% 17.48% 22.77% 32.77% 33.33% 19.16% 21.12% 22.16% 17.43% 20.51% 0.00%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($11.85) ($0.15) $5.54 $2.97 $4.39 $4.39 $4.02 $3.00 $0.83 $1.89 $3.06
Adjusted Weighted Average Basic Shares Outstanding
36.35M 36.24M 37.15M 39.00M 40.47M 41.83M 41.62M 42.08M 42.13M 42.10M 0.00
Adjusted Diluted Earnings per Share
($11.85) ($0.15) $5.50 $2.95 $4.37 $4.35 $3.97 $2.97 $0.83 $1.89 $3.06
Adjusted Weighted Average Diluted Shares Outstanding
36.35M 36.24M 37.15M 39.00M 40.47M 41.83M 41.62M 42.08M 42.13M 42.10M 0.00
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
36.35M 36.24M 37.15M 39.00M 40.47M 41.83M 41.62M 42.08M 42.13M 42.10M 0.00
Normalized Net Operating Profit after Tax (NOPAT)
182 179 258 223 226 240 215 168 73 91 138
Normalized NOPAT Margin
12.94% 10.61% 15.47% 16.02% 18.62% 18.54% 19.01% 17.25% 8.03% 9.54% 13.33%
Pre Tax Income Margin
-38.08% -0.60% 16.16% 11.70% 19.33% 17.63% 19.57% 17.98% 9.58% 14.24% 19.52%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-4.56 0.82 5.24 4.07 5.89 5.03 7.58 10.53 5.44 7.79 13.32
NOPAT to Interest Expense
-1.97 0.62 4.11 4.07 4.48 3.99 6.24 8.77 2.69 4.78 8.64
EBIT Less CapEx to Interest Expense
-5.35 -0.35 2.94 2.06 4.14 2.93 4.75 7.62 2.50 2.77 7.12
NOPAT Less CapEx to Interest Expense
-2.77 -0.56 1.81 2.07 2.73 1.89 3.41 5.86 -0.25 -0.24 2.43
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 52.42% 8.47% 1,022.30% 4.03% 2.34%
Augmented Payout Ratio
0.00% -1,705.56% 68.62% 92.63% 48.51% 3.48% 78.49% 13.02% 1,022.30% 4.03% 2.34%

Quarterly Metrics And Ratios for Ingevity

This table displays calculated financial ratios and metrics derived from Ingevity's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-16.50% -19.61% -15.49% -18.93% -13.37% -3.10% -7.47% 14.74% 2.56% 14.17% 27.92%
EBITDA Growth
455.50% 203.33% -202.45% -384.95% -117.42% -214.87% -35.49% -15.08% -0.52% -10.66% 340.40%
EBIT Growth
193.15% 150.97% -306.70% -549.35% -159.26% -388.33% -48.56% -24.35% -5.21% -21.13% 4,026.92%
NOPAT Growth
415.89% 237.34% -103.63% -522.64% -123.51% -354.88% -48.44% -26.69% -23.91% -19.77% 40.93%
Net Income Growth
136.61% 114.21% -525.40% -899.15% -210.45% -848.72% -66.58% -40.64% -16.61% -46.76% 1,895.24%
EPS Growth
136.36% 114.24% -527.54% -905.15% -214.07% -834.88% -65.15% -37.01% -12.90% -43.42% 1,900.00%
Operating Cash Flow Growth
309.92% 39.61% -55.80% -38.64% -328.30% -53.10% 5.09% -46.52% -78.19% 29.10% 0.00%
Free Cash Flow Firm Growth
174.52% 3,471.90% 252.23% 164.90% 144.76% 104.08% -1,894.77% -505.99% -918.55% -944.81% -85.16%
Invested Capital Growth
-21.13% -23.69% -25.14% -22.61% -8.28% -4.41% 22.80% 27.79% 24.44% 25.60% 4.04%
Revenue Q/Q Growth
-4.95% -20.72% -3.51% 14.85% -8.50% -16.66% -7.43% 22.72% 2.35% -20.41% 14.79%
EBITDA Q/Q Growth
-11.79% 191.70% 69.06% -1,320.50% 76.08% -190.91% -13.94% -13.15% 71.60% -48.95% 13.29%
EBIT Q/Q Growth
-16.61% 148.55% 63.36% -527.82% 54.37% -296.92% -20.35% -17.20% 128.07% -64.86% 17.14%
NOPAT Q/Q Growth
-63.18% 6,590.97% 99.26% -1,689.66% 83.99% -271.55% -14.00% -0.45% 81.73% -65.30% 22.28%
Net Income Q/Q Growth
23.49% 115.49% 62.21% -406.61% 52.05% -563.49% -29.01% -29.98% 225.00% -79.31% 26.09%
EPS Q/Q Growth
24.44% 115.25% 62.23% -407.14% 51.27% -557.97% -28.87% -28.15% 213.95% -78.28% 28.57%
Operating Cash Flow Q/Q Growth
-60.62% 38.71% 56.57% 345.45% -127.13% -56.08% 117.36% 813.21% -94.62% -1.60% 10.61%
Free Cash Flow Firm Q/Q Growth
-21.33% 9.66% 93.32% 64.61% 923.57% 104.67% 17.58% -13.52% 6.98% -2,155.06% -81.36%
Invested Capital Q/Q Growth
1.83% -3.11% -6.19% -14.78% -1.48% -4.95% -3.02% 0.99% 2.68% 22.11% 0.92%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
39.93% 34.10% 34.47% 31.54% 29.31% 16.01% 28.92% 31.76% 33.21% 27.48% 36.58%
EBITDA Margin
25.04% 26.97% -23.32% -72.73% -5.88% -20.98% 19.24% 20.69% 29.24% 17.70% 27.59%
Operating Margin
17.71% 18.54% -0.61% -79.72% -5.12% -29.24% 12.67% 14.38% 16.68% 9.83% 22.68%
EBIT Margin
16.27% 18.54% -30.27% -79.72% -14.58% -29.24% 12.38% 14.38% 21.32% 9.83% 22.26%
Profit (Net Income) Margin
7.22% 5.56% -28.44% -72.63% -16.47% -31.42% 5.65% 7.37% 12.91% 4.07% 15.64%
Tax Burden Percent
76.49% 188.64% 77.74% 84.79% 77.89% 75.84% 78.50% 74.42% 79.10% 79.19% 78.71%
Interest Burden Percent
58.01% 15.88% 120.86% 107.45% 144.96% 141.67% 58.15% 68.83% 76.58% 52.25% 89.28%
Effective Tax Rate
23.51% -88.64% 0.00% 0.00% 0.00% 0.00% 21.50% 25.58% 20.90% 20.81% 21.29%
Return on Invested Capital (ROIC)
10.37% 27.86% -0.34% -44.84% -2.85% -16.91% 8.87% 9.62% 11.41% 6.90% 17.19%
ROIC Less NNEP Spread (ROIC-NNEP)
9.05% 21.36% -8.02% -49.45% -5.94% -19.85% 7.32% 8.34% 11.33% 5.71% 16.18%
Return on Net Nonoperating Assets (RNNOA)
30.73% 69.88% -23.64% -141.33% -13.00% -41.32% 13.36% 15.25% 19.80% 9.95% 26.40%
Return on Equity (ROE)
41.10% 97.75% -23.98% -186.17% -15.85% -58.22% 22.23% 24.87% 31.21% 16.85% 43.59%
Cash Return on Invested Capital (CROIC)
15.38% 15.95% 12.04% 11.65% 8.63% 7.33% -11.24% -13.12% -9.58% -9.18% 11.58%
Operating Return on Assets (OROA)
9.50% 11.23% -17.99% -48.37% -8.96% -18.46% 8.27% 9.64% 13.69% 6.30% 15.15%
Return on Assets (ROA)
4.22% 3.36% -16.90% -44.06% -10.11% -19.84% 3.77% 4.94% 8.29% 2.61% 10.65%
Return on Common Equity (ROCE)
41.10% 97.75% -23.98% -186.17% -15.85% -58.22% 22.23% 24.87% 31.21% 16.85% 43.59%
Return on Equity Simple (ROE_SIMPLE)
-150.81% 0.00% -262.80% -151.44% -19.73% 0.00% 17.67% 24.81% 27.77% 0.00% 35.54%
Net Operating Profit after Tax (NOPAT)
38 105 -1.61 -218 -12 -76 44 52 52 30 86
NOPAT Margin
13.55% 34.97% -0.43% -55.81% -3.58% -20.47% 9.95% 10.70% 13.20% 7.78% 17.85%
Net Nonoperating Expense Percent (NNEP)
1.32% 6.50% 7.68% 4.60% 3.10% 2.94% 1.55% 1.28% 0.09% 1.19% 1.02%
Return On Investment Capital (ROIC_SIMPLE)
2.36% 6.55% - - - -3.63% - - - 1.37% -
Cost of Revenue to Revenue
60.07% 65.90% 65.53% 68.46% 70.69% 83.99% 71.08% 68.24% 66.79% 72.52% 63.42%
SG&A Expenses to Revenue
15.18% 13.19% 10.27% 10.60% 13.88% 11.68% 8.97% 10.73% 12.38% 14.57% 11.24%
R&D to Revenue
2.71% 2.44% 1.78% 1.87% 2.00% 1.94% 1.75% 1.66% 2.24% 1.88% 1.58%
Operating Expenses to Revenue
22.22% 15.56% 35.08% 111.26% 34.43% 45.25% 16.26% 17.37% 16.53% 17.65% 13.90%
Earnings before Interest and Taxes (EBIT)
46 55 -114 -311 -50 -109 55 69 84 38 107
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
71 81 -88 -284 -20 -78 86 100 115 68 133
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
6.13 7.59 6.61 5.58 3.04 2.71 2.40 2.96 3.66 3.77 3.64
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.07 1.05 0.96 1.03 1.05 1.01 1.01 1.21 1.58 1.58 1.42
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 13.58 11.92 13.19 12.44 10.24
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 7.36% 8.39% 7.58% 8.04% 9.77%
Enterprise Value to Invested Capital (EV/IC)
1.77 1.84 1.76 1.78 1.59 1.54 1.48 1.64 1.90 1.92 1.98
Enterprise Value to Revenue (EV/Rev)
2.04 2.00 1.88 1.93 1.91 1.82 1.83 2.05 2.43 2.42 2.09
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 48.28 15.43 8.90 8.98 9.45 9.31 7.67
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 40.08 13.69 12.75 12.79 12.44 10.12
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 53.31 17.64 16.36 17.25 15.85 12.95
Enterprise Value to Operating Cash Flow (EV/OCF)
16.62 21.88 25.21 17.66 16.69 15.03 12.09 14.16 13.87 12.86 11.64
Enterprise Value to Free Cash Flow (EV/FCFF)
10.17 10.00 12.54 13.30 17.61 20.53 0.00 0.00 0.00 0.00 17.39
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
5.94 7.18 6.99 5.28 2.63 2.32 2.05 2.14 2.07 2.11 1.82
Long-Term Debt to Equity
5.68 6.86 6.52 4.92 2.48 2.19 2.04 2.14 2.07 2.11 1.82
Financial Leverage
3.40 3.27 2.95 2.86 2.19 2.08 1.83 1.83 1.75 1.74 1.63
Leverage Ratio
5.76 5.62 5.33 5.11 4.13 4.03 3.77 3.80 3.70 3.79 3.72
Compound Leverage Factor
3.34 0.89 6.45 5.49 5.98 5.71 2.19 2.61 2.84 1.98 3.33
Debt to Total Capital
85.59% 87.77% 87.48% 84.08% 72.44% 69.91% 67.20% 68.13% 67.44% 67.85% 64.55%
Short-Term Debt to Total Capital
3.71% 3.84% 5.88% 5.76% 4.11% 4.02% 0.14% 0.04% 0.04% 0.04% 0.05%
Long-Term Debt to Total Capital
81.88% 83.93% 81.60% 78.32% 68.33% 65.89% 67.07% 68.09% 67.40% 67.80% 64.50%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
14.41% 12.23% 12.52% 15.92% 27.56% 30.09% 32.80% 31.87% 32.56% 32.15% 35.45%
Debt to EBITDA
-5.66 -4.15 -4.60 -5.72 23.01 7.35 4.21 3.84 3.48 3.41 2.61
Net Debt to EBITDA
-5.37 -3.95 -4.18 -5.31 21.65 6.87 3.97 3.67 3.30 3.23 2.45
Long-Term Debt to EBITDA
-5.41 -3.97 -4.29 -5.33 21.71 6.92 4.20 3.84 3.48 3.40 2.61
Debt to NOPAT
-9.57 -7.26 -4.87 -5.64 -7,111.43 25.38 8.35 6.99 6.35 5.80 4.41
Net Debt to NOPAT
-9.08 -6.91 -4.43 -5.24 -6,690.00 23.72 7.87 6.68 6.02 5.49 4.14
Long-Term Debt to NOPAT
-9.15 -6.94 -4.54 -5.25 -6,708.10 23.92 8.33 6.99 6.35 5.79 4.41
Altman Z-Score
1.76 1.80 1.43 1.29 1.76 1.69 1.94 2.03 2.21 2.11 2.44
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.00 1.87 1.77 1.92 1.90 1.81 2.41 2.46 2.57 2.25 2.22
Quick Ratio
0.89 0.79 0.90 0.90 0.80 0.77 0.99 1.05 1.14 0.99 1.10
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
455 579 528 273 166 16 -347 -421 -371 -397 19
Operating Cash Flow to CapEx
396.88% 259.04% 258.33% 164.09% -72.89% 158.22% 314.03% 223.04% 20.87% 200.20% 277.29%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.58 0.61 0.59 0.61 0.61 0.63 0.67 0.67 0.64 0.64 0.68
Accounts Receivable Turnover
7.61 0.00 7.28 6.55 7.60 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
3.09 3.55 3.29 3.30 3.49 3.79 3.55 3.54 3.59 3.81 4.12
Fixed Asset Turnover
1.95 1.98 2.01 2.03 2.14 2.17 2.24 0.00 2.20 0.00 2.28
Accounts Payable Turnover
6.75 7.53 7.26 6.57 7.33 7.32 6.56 6.32 7.37 7.31 7.20
Days Sales Outstanding (DSO)
47.98 0.00 50.15 55.76 48.05 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
118.14 102.71 110.78 110.61 104.61 96.29 102.85 103.16 101.71 95.75 88.58
Days Payable Outstanding (DPO)
54.09 48.50 50.25 55.54 49.80 49.84 55.68 57.77 49.54 49.95 50.70
Cash Conversion Cycle (CCC)
112.03 54.21 110.68 110.83 102.86 46.46 47.17 45.39 52.16 45.80 37.87
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,556 1,528 1,577 1,681 1,973 2,003 2,107 2,173 2,151 2,095 1,716
Invested Capital Turnover
0.77 0.80 0.80 0.80 0.80 0.83 0.89 0.90 0.87 0.89 0.96
Increase / (Decrease) in Invested Capital
-417 -475 -530 -491 -178 -92 391 472 423 427 67
Enterprise Value (EV)
2,761 2,814 2,780 2,985 3,133 3,082 3,113 3,571 4,083 4,029 3,389
Market Capitalization
1,439 1,481 1,417 1,588 1,728 1,711 1,725 2,113 2,657 2,632 2,307
Book Value per Share
$6.45 $5.37 $5.90 $7.84 $15.64 $17.43 $19.84 $19.66 $19.53 $18.69 $16.66
Tangible Book Value per Share
($6.13) ($7.12) ($7.46) ($5.17) ($7.17) ($6.41) ($4.89) ($5.70) ($5.25) ($6.02) ($0.68)
Total Capital
1,628 1,596 1,713 1,789 2,062 2,099 2,191 2,241 2,229 2,172 1,788
Total Debt
1,393 1,401 1,498 1,504 1,493 1,467 1,473 1,526 1,503 1,473 1,154
Total Long-Term Debt
1,333 1,340 1,398 1,401 1,409 1,383 1,470 1,526 1,503 1,473 1,153
Net Debt
1,322 1,333 1,363 1,397 1,405 1,371 1,388 1,458 1,426 1,397 1,082
Capital Expenditures (CapEx)
6.40 25 18 18 17 29 34 22 25 49 36
Debt-free, Cash-free Net Working Capital (DFCFNWC)
254 222 241 324 314 284 348 386 361 304 283
Debt-free Net Working Capital (DFNWC)
326 290 377 431 402 380 432 454 438 381 356
Net Working Capital (NWC)
265 229 276 328 318 296 429 453 438 380 355
Net Nonoperating Expense (NNE)
18 88 106 66 44 41 19 16 1.11 14 11
Net Nonoperating Obligations (NNO)
1,322 1,333 1,363 1,397 1,405 1,371 1,388 1,458 1,426 1,397 1,082
Total Depreciation and Amortization (D&A)
25 25 26 27 30 31 31 30 31 30 26
Debt-free, Cash-free Net Working Capital to Revenue
18.83% 15.81% 16.31% 20.90% 19.13% 16.80% 20.42% 22.20% 21.48% 18.22% 17.49%
Debt-free Net Working Capital to Revenue
24.13% 20.65% 25.46% 27.84% 24.53% 22.46% 25.38% 26.10% 26.12% 22.82% 21.95%
Net Working Capital to Revenue
19.65% 16.29% 18.66% 21.18% 19.36% 17.48% 25.20% 26.05% 26.07% 22.77% 21.89%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.56 $0.45 ($2.95) ($7.81) ($1.54) ($3.19) $0.70 $0.98 $1.36 $0.44 $1.99
Adjusted Weighted Average Basic Shares Outstanding
36.46M 36.35M 36.35M 36.35M 36.33M 36.24M 36.23M 36.22M 36.33M 37.15M 37.37M
Adjusted Diluted Earnings per Share
$0.56 $0.45 ($2.95) ($7.81) ($1.54) ($3.16) $0.69 $0.97 $1.35 $0.43 $1.98
Adjusted Weighted Average Diluted Shares Outstanding
36.46M 36.35M 36.35M 36.35M 36.33M 36.24M 36.23M 36.22M 36.33M 37.15M 37.37M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
36.46M 36.35M 36.35M 36.35M 36.33M 36.24M 36.23M 36.22M 36.33M 37.15M 37.37M
Normalized Net Operating Profit after Tax (NOPAT)
38 99 59 35 -12 12 64 67 53 32 88
Normalized NOPAT Margin
13.55% 33.24% 15.69% 9.07% -3.52% 3.30% 14.29% 13.95% 13.58% 8.42% 18.16%
Pre Tax Income Margin
9.44% 2.95% -36.59% -85.66% -21.14% -41.43% 7.20% 9.90% 16.33% 5.14% 19.88%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% -52.36% -1,705.56% 77.24% 83.18% 68.59% 68.62% 65.82%

Frequently Asked Questions About Ingevity's Financials

When does Ingevity's fiscal year end?

According to the most recent income statement we have on file, Ingevity's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Ingevity's net income changed over the last 10 years?

Ingevity's net income appears to be on a downward trend, with a most recent value of -$430.30 million in 2024, falling from $132.60 million in 2014. The previous period was -$5.40 million in 2023. See where experts think Ingevity is headed by visiting Ingevity's forecast page.

What is Ingevity's operating income?
Ingevity's total operating income in 2024 was -$275.70 million, based on the following breakdown:
  • Total Gross Profit: $454.70 million
  • Total Operating Expenses: $730.40 million
How has Ingevity revenue changed over the last 10 years?

Over the last 10 years, Ingevity's total revenue changed from $1.04 billion in 2014 to $1.41 billion in 2024, a change of 35.8%.

How much debt does Ingevity have?

Ingevity's total liabilities were at $1.83 billion at the end of 2024, a 8.3% decrease from 2023, and a 599.3% increase since 2015.

How much cash does Ingevity have?

In the past 9 years, Ingevity's cash and equivalents has ranged from $30.50 million in 2016 to $275.40 million in 2021, and is currently $68 million as of their latest financial filing in 2024.

How has Ingevity's book value per share changed over the last 10 years?

Over the last 10 years, Ingevity's book value per share changed from 0.00 in 2014 to 5.37 in 2024, a change of 537.0%.



This page (NYSE:NGVT) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners